Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

FUSNFUSN
5 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in FUSION PHARMACEUTICALS INC

As of its Q1 2024 13F, Bank of America held 71,496 shares of FUSN (Fusion Pharmaceuticals), worth $1.5M. Bank of America's 13F filings listed FUSN from Q2 2023 to Q1 2024, 4 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$10,858

Total Shares Change

-2,325

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q1
Increased
71,496
+5114.9%
$1.5M0.0%—
41
2023-Q4
Decreased
1,371
-11.4%
$13,1750.0%—
0
2023-Q3
Decreased
1,547
-33.5%
$4,0220.0%—
0
2023-Q2
New
2,325
-
$10,8580.0%—
26

Other major holders of FUSN: FEDERATED HERMES, INC., FIL Ltd, Pentwater Capital Management LP, CANADA PENSION PLAN INVESTMENT BOARD

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used